Results 101 to 110 of about 4,189,272 (208)

Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum

open access: yesCancers, 2018
Aberrant epigenetic modifications are an early event in carcinogenesis, with the epigenetic landscape continuing to change during tumor progression and metastasis—these observations suggest that specific epigenetic modifications could be used as ...
M. L. Thomas, P. Marcato
semanticscholar   +1 more source

Acute kidney injury in critically ill cancer patients : an update [PDF]

open access: yes, 2016
Patients with cancer represent a growing group among actual ICU admissions (up to 20 %). Due to their increased susceptibility to infectious and noninfectious complications related to the underlying cancer itself or its treatment, these patients ...
Benoit, Dominique   +3 more
core   +2 more sources

Noninvasive Technologies for the Diagnosis of Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

open access: yesJID Innovations
Early cutaneous squamous cell carcinoma (cSCC) diagnosis is essential to initiate adequate targeted treatment. Noninvasive diagnostic technologies could overcome the need of multiple biopsies and reduce tumor recurrence.
Carina Nogueira Garcia   +3 more
doaj   +1 more source

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial

open access: yesCells, 2019
The management of patients with colorectal cancer (CRC) and potentially resectable liver metastases (LM) requires quick assessment of mutational status and of response to pre-operative systemic therapy.
François-Clément Bidard   +22 more
doaj   +1 more source

Circulating biomarkers predictive of tumor response to cancer immunotherapy

open access: yesExpert Review of Molecular Diagnostics, 2019
Introduction: The advent of checkpoint blockade immunotherapy has revolutionized cancer treatment, but clinical response to immunotherapies is highly heterogeneous among individual patients and between cancer types.
Ernest Y Lee, Rajan P. Kulkarni
semanticscholar   +1 more source

Advances in research on exosome biomarkers in common malignant brain tumors

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2019
Extracellular vesicles (EVs) can be divided into apoptotic bodies, microvesicles and exosomes based on their origin and size. Exosomes are among the smallest and most characteristic vesicles that can be secreted by different types of cells, including ...
Xiao⁃yu WU, Liang⁃yi ZHU, Qing CHANG
doaj  

Oxygen-Enhanced and Dynamic Contrast-Enhanced Optoacoustic Tomography Provide Surrogate Biomarkers of Tumor Vascular Function, Hypoxia, and Necrosis.

open access: yesCancer Research, 2018
Measuring the functional status of tumor vasculature, including blood flow fluctuations and changes in oxygenation, is important in cancer staging and therapy monitoring.
M. Tomaszewski   +5 more
semanticscholar   +1 more source

Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers

open access: yesCancer Management and Research, 2018
Neoadjuvant therapy (NAT) has been used increasingly in patients with locally advanced or early-stage breast cancer. However, the accurate evaluation and prediction of response to NAT remain the great challenge.
W. Tan   +4 more
semanticscholar   +1 more source

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma

open access: yesMolecular Cancer
Liver cancer is a global health challenge, causing a significant social-economic burden. Hepatocellular carcinoma (HCC) is the predominant type of primary liver cancer, which is highly heterogeneous in terms of molecular and cellular signatures.
Y. Chan   +8 more
semanticscholar   +1 more source

Author Correction: The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma

open access: yesScientific Reports, 2023
Caroline E. Nunes‑Xavier   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy